Wedbush Tesla · TSLA

Wedbush Keeps Outperform on Tesla, $550 Price Target

February 20, 2025 Analyst: Daniel Ives 1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$550
Outcome
Missed
within 12 months
Wedbush and Tesla logos

What the analyst said

Wedbush analyst Daniel Ives reiterated an Outperform rating and $550 price target on Tesla (NASDAQ: TSLA).

“The worry of the Street is that Musk dedicating so much time (even more than we expected) to DOGE takes away from his time at Tesla in such a crucial moment and year for the company.

The autonomous and robotics battle for market share is in full force both in the US and China and many on the Street view Musk spending “100% of his time” with DOGE as creating a negative perception around his Tesla focus.

The bears will now focus on this DOGE issue, isolated protests, brand worries as their latest narrative, but the reality is this does not change the future of Tesla.We believe while perception is reality, this is off base as our work in the field shows Tesla gearing up for a new mass market vehicle launch in 1H25, making major product developments around autonomous/Optimus across its global production ecosystem, Austin unsupervised FSD launch set for June, and a host of other growth EV/battery catalysts on the horizon.

Musk has always been able to balance his countless initiatives better than any other CEO we have seen and the innovation and tech machine at Tesla is accelerating into an autonomous/robotics future despite growing skepticism around Musk’s DOGE balancing act.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

TSLA trades at $355. The 19 analysts who set a target in the last 3 months range from $24.86 to $500, with a median of $450. This $550 target is 22% above the median, the highest on the Street.

Since the note TSLA has moved −2% (from $361). The 12-month window closed on February 20, 2026.

Track record

This call✗ Not reached within 12 months: a year after the note TSLA closed at $449, 18% below the $550 target, but it moved the way the analyst expected. Same target as this firm’s January 22, 2025 note, so it is scored there.

Firm track recordWedbush: 25% of its 8 targets at least a year old were reached within 12 months (#28 of 28 firms); on Tesla, 2 of 8. Accuracy ranking →

Wedbush on Tesla

Wedbush price targets on Tesla

8 calls from September 5, 2025 to April 2, 2026. The target went from $500 to $600 (+20%). The rating stayed Buy.

Wedbush targetTSLA share price
  1. April 2, 2026Kept the $600 targetBuy$600
  2. January 2, 2026Kept the $600 targetBuy$600
  3. December 15, 2025Kept the $600 targetBuy$600
  4. October 23, 2025Kept the $600 targetBuy$600
  5. October 20, 2025Kept the $600 targetBuy$600
  6. October 7, 2025Kept the $600 targetBuy$600
  7. September 26, 2025Target raised from $500 (+20%)Buy$600
  8. September 5, 2025Earliest call shownBuy$500
Share

Other analysts on Tesla

JP MorganHold Kept rating and price target · Oct 16 $415maintained Yorkville IvesBuy Kept rating and price target · Oct 12 $500maintained Yorkville IvesBuy Initiated coverage · Oct 7 $500 UBSHold Raised price target +2%, kept rating · Oct 7 $391from $385 Goldman SachsHold Kept rating and price target · Oct 6 $360maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.